Why Alnylam Pharmaceuticals, Inc. (ALNY) stock rose 5.3% intraday on Friday, November 13, 2026
Alnylam Pharmaceuticals, Inc. (ALNY) traded at $165.04 as of 11:31 AM ET, up 5.35% on Friday, November 13, 2026, on volume of 1,320,116 shares (0.7× its 3-month average); market value about $22.10B, according to Nexqual market data (nexqual.com/moves/2026-11-13/ALNY).
ALNY was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.
What happened: primary sources
Events Nexqual found for ALNY on Friday, November 13, 2026 or the trading day before (November 12, 2026), each linked to its primary source:
- Nov 10, 2026: Form 4: Sigal Charles Elliott (Director) bought 1,600 shares ($243,600) on the open market source
- Nov 9, 2026: Form 4: Schulman Amy W (Director) bought 1,910 shares ($299,526) on the open market source
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on ALNY
ALNY stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 13, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:31 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt